148 related articles for article (PubMed ID: 21950682)
1. Validity of HMGB1 measurement in epithelial lining fluid in patients with COPD.
Kanazawa H; Tochino Y; Asai K; Ichimaru Y; Watanabe T; Hirata K
Eur J Clin Invest; 2012 Apr; 42(4):419-26. PubMed ID: 21950682
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of N(epsilon)-(carboxymethyl)lysine in epithelial lining fluid from peripheral airways in patients with chronic obstructive pulmonary disease: a pilot study.
Kanazawa H; Kodama T; Asai K; Matsumura S; Hirata K
Clin Sci (Lond); 2010 May; 119(3):143-9. PubMed ID: 20236091
[TBL] [Abstract][Full Text] [Related]
3. Measurement of soluble perforin, a marker of CD8+ T lymphocyte activation in epithelial lining fluid.
Shiratsuchi N; Asai K; Kanazawa H; Kyoh S; Tochino Y; Kodama T; Hirata K
Respir Med; 2011 Dec; 105(12):1885-90. PubMed ID: 21827966
[TBL] [Abstract][Full Text] [Related]
4. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M
Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931
[TBL] [Abstract][Full Text] [Related]
5. A technological advance comparing epithelial lining fluid from different regions of the lung in smokers.
Kodama T; Kanazawa H; Tochino Y; Kyoh S; Asai K; Hirata K
Respir Med; 2009 Jan; 103(1):35-40. PubMed ID: 18930648
[TBL] [Abstract][Full Text] [Related]
6. [Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients].
Zhang JQ; Lao QF; Chu SY; Bai J; Zhong XN
Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1431-5. PubMed ID: 20646637
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and airway inflammation in severe exacerbations of COPD.
Drost EM; Skwarski KM; Sauleda J; Soler N; Roca J; Agusti A; MacNee W
Thorax; 2005 Apr; 60(4):293-300. PubMed ID: 15790984
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous assessment of hepatocyte growth factor and vascular endothelial growth factor in epithelial lining fluid from patients with COPD.
Kanazawa H; Tochino Y; Asai K; Hirata K
Chest; 2014 Nov; 146(5):1159-1165. PubMed ID: 24832895
[TBL] [Abstract][Full Text] [Related]
9. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
[TBL] [Abstract][Full Text] [Related]
11. [Levels of HMGB1 in induced sputum from patients with asthma and chronic obstructive pulmonary disease].
Cheng Z; Kang Y; Wu QG; Dai LL; Song YN; Xia J; Si JM; Chen CY
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):2981-4. PubMed ID: 22333024
[TBL] [Abstract][Full Text] [Related]
12. Relationship between airway colonization, inflammation and exacerbation frequency in COPD.
Tumkaya M; Atis S; Ozge C; Delialioglu N; Polat G; Kanik A
Respir Med; 2007 Apr; 101(4):729-37. PubMed ID: 17002892
[TBL] [Abstract][Full Text] [Related]
13. Possible role of airway microvascular permeability on airway obstruction in patients with chronic obstructive pulmonary disease.
Kyomoto Y; Kanazawa H; Tochino Y; Watanabe T; Asai K; Kawaguchi T
Respir Med; 2019 Jan; 146():137-141. PubMed ID: 30665512
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the severity of small airways obstruction and alveolar destruction in chronic obstructive pulmonary disease.
Kawamoto T; Kanazawa H; Tochino Y; Kawaguchi T
Respir Med; 2018 Aug; 141():159-164. PubMed ID: 30053962
[TBL] [Abstract][Full Text] [Related]
15. High expression of high-mobility group box 1 in the blood and lungs is associated with the development of chronic obstructive pulmonary disease in smokers.
Ko HK; Hsu WH; Hsieh CC; Lien TC; Lee TS; Kou YR
Respirology; 2014 Feb; 19(2):253-261. PubMed ID: 24372740
[TBL] [Abstract][Full Text] [Related]
16. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
[TBL] [Abstract][Full Text] [Related]
17. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
[TBL] [Abstract][Full Text] [Related]
18. Airway inflammatory markers in chronic obstructive pulmonary disease patients and healthy smokers.
Hacievliyagil SS; Mutlu LC; Temel İ
Niger J Clin Pract; 2013; 16(1):76-81. PubMed ID: 23377476
[TBL] [Abstract][Full Text] [Related]
19. MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients.
Caramori G; Casolari P; Di Gregorio C; Saetta M; Baraldo S; Boschetto P; Ito K; Fabbri LM; Barnes PJ; Adcock IM; Cavallesco G; Chung KF; Papi A
Histopathology; 2009 Sep; 55(3):321-31. PubMed ID: 19723147
[TBL] [Abstract][Full Text] [Related]
20. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease.
Lommatzsch M; Cicko S; Müller T; Lucattelli M; Bratke K; Stoll P; Grimm M; Dürk T; Zissel G; Ferrari D; Di Virgilio F; Sorichter S; Lungarella G; Virchow JC; Idzko M
Am J Respir Crit Care Med; 2010 May; 181(9):928-34. PubMed ID: 20093639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
